Reaction Details Report a problem with these data
Target
GTPase KRas [1-169,G12C,C118A]
Ligand
BDBM515908
Substrate
n/a
Meas. Tech.
Coupled Nucleotide Exchange Assay (2 hours)
IC50
120.00±n/a nM
Citation
 Shin, Y; Cee, VJ; Tegley, CM; Lanman, BA; Wurz, RP; Yang, KC; Ma, VV; Erlanson, D; Jeong, JW; Fucini, RV; Iwig, J KRAS G12C inhibitors and methods of using the same US Patent  US11053226 Publication Date 7/6/2021 
Target
Name:
GTPase KRas [1-169,G12C,C118A]
Synonyms:
GTPase KRas | KRAS | KRAS2 | RASK2 | RASK_HUMAN
Type:
PROTEIN
Mol. Mass.:
19407.24
Organism:
Homo sapiens (Human)
Description:
P01116[1-169,G12C,C118A]
Residue:
169
Sequence:
MTEYKLVVVGACGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETCLLDILDTAGQEEYSAMRDQYMRTGEGFLCVFAINNTKSFEDIHHYREQIKRVKDSEDVPMVLVGNKADLPSRTVDTKQAQDLARSYGIPFIETSAKTRQRVEDAFYTLVREIRQYRLK
  
Inhibitor
Name:
BDBM515908
Synonyms:
2-(5-Chloro-2-cyclopropyl- 3-((5-methoxy-3,4- dihydro-2(1H)- isoquinolinyl)carbonyl)- 7-methyl-1H-indol-1- yl)-N-methyl-N-(1-(2- propenoyl)-3- azetidinyl)acetamide | US11053226, Example 4-3
Type:
Small organic molecule
Emp. Form.:
C32H35ClN4O4
Mol. Mass.:
575.098
SMILES:
COc1cccc2CN(CCc12)C(=O)c1c(C2CC2)n(CC(=O)N(C)C2CN(C2)C(=O)C=C)c2c(C)cc(Cl)cc12
Structure:
Search PDB for entries with ligand similarity: